SLC44A2

Mengen Xing1,2, Wanqi Chen1,2, Yachen Ji1,2

  • 1Institute of Aging, Key Laboratory of Alzheimer's Disease of Zhejiang Province, School of Mental Health and Affiliated Kangning Hospital, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.

概括

血管光滑细胞 (VSMC) 切换驱动大动脉动脉瘤 (AA). 研究人员发现SLC44A2保留了VSMC收缩功能,并且抑制它会使AA恶化. 准SLC44A2可以预防和治疗AA.